Open help menu
Live Webinar

Medication Assisted Therapy

|

References

References

  • Substance Abuse and Mental Health Services Administration. (2018). TIP 63: Medications for opioid use disorder; TIP 49: Pharmacotherapy for alcohol use disorder; MAT overview, regulations, and patient education materials. U.S. Department of Health and Human Services.
  • National Institute on Drug Abuse. (2020). Neurobiology of addiction, evidence base for medication-assisted treatment, outcomes data, and clinician education. National Institutes of Health.
  • Centers for Disease Control and Prevention. (2022). Overdose prevention, opioid prescribing guidance, and epidemiology. U.S. Department of Health and Human Services.
  • McPheeters, M., O’Connor, E. A., Riley, S., Kennedy, S. M., Voisin, C., Kuznacic, K., Coffey, C. P., Edlund, M. J., Bobashev, G., & Jonas, D. E. (2023). Pharmacotherapy for alcohol use disorder: A systematic review and meta-analysis. JAMA, 330(17), 1653–1665. https://doi.org/10.1001/jama.2023.19761
  • Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. BMJ, 357, Article j1550. https://doi.org/10.1136/bmj.j1550
  • Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, (3), Article CD002209. https://doi.org/10.1002/14651858.CD002209.pub2
  • Lee, J. D., Nunes, E. V. Jr., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., King, J., Lindblad, R., Liu, D., Matthews, A. G., May, J., Peavy, M., Ross, S., Salazar, D., Schkolnik, P., Shmueli-Blumberg, D., Stablein, D., Subramaniam, G., & Rotrosen, J. (2018). Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial. The Lancet, 391(10118), 309–318. https://doi.org/10.1016/S0140-6736(17)32812-X